Evoke Pharma competitorsClear all

Evoke Pharma's top competitors include Inovio Pharmaceuticals, Reata Pharmaceuticals, Otonomy and Alimera Sciences.
Evoke Pharma
Evoke Pharma
Evoke Pharma is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI) diseases.
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Alimera Sciences
Alimera Sciences
Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
Founding Date
Founding Date
2007
Founding Date
1979
Founding Date
2002
Founding Date
2008
Founding Date
2003
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Solana Beach, US HQ
Locations
Plymouth Meeting, US HQ
San Diego, US
San Diego, US
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
San Diego, US HQ
Locations
Alpharetta, US HQ
Berlin, DE
Dublin 2, IE
Lisboa, PT
Hampshire, GB
Employees
Employees
614% decrease
Employees
2811% increase
Employees
22079% increase
Employees
49
Employees
1222% decrease
Valuation ($)
Valuation ($)
123 m
Valuation ($)
2.7 b
Valuation ($)
3.1 b
Valuation ($)
164.5 m
Valuation ($)
25.3 m
Twitter followers
Twitter followers
N/A
Twitter followers
15 k
Twitter followers
952
Twitter followers
226
Twitter followers
2.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
200.6
Average likes per tweet (last 30 days)
4.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
93.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
296349
Alexa Website Rank
181842
Alexa Website Rank
365810
Alexa Website Rank
339305
Alexa Website Rank
344430
Employee Rating
Employee Rating
N/A
Employee Rating
3.6
Employee Rating
4
Employee Rating
4.3
Employee Rating
3.8

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$4.1m (FY, 2019)
Revenue (est.)
$26.5m (FY, 2019)
Revenue (est.)
$600k (FY, 2019)
Revenue (est.)
$53.9m (FY, 2019)
Net income
Net income
($7.1m) (FY, 2019)
Net income
($120.6m) (FY, 2019)
Net income
($290.2m) (FY, 2019)
Net income
($44.7m) (FY, 2019)
Net income
($10.4m) (FY, 2019)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
620 (FY, 2016)
Patents Issued
240 (FY, 2016)
Patents Issued
88 (FY, 2016)
Patents Issued
N/A
Patents Pending
Patents Pending
N/A
Patents Pending
N/A
Patents Pending
280 (FY, 2016)
Patents Pending
115 (FY, 2016)
Patents Pending
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 202.6m
Total funding raised
$ 468.9m
Total funding raised
$ 153.4m
Total funding raised
$ 232.6m
For sources of this data, please see the company profile

View company profiles

Inovio Pharmaceuticals
HQ
Plymouth Meeting, US
Employees
281↑ 1% increase

Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.

View company
Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.

View company
Otonomy
HQ
San Diego, US
Employees
49

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company
Alimera Sciences
HQ
Alpharetta, US
Employees
122↓ 2% decrease

Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.

View company